InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-0.73%
Return on Equity-1.06%
Return on Assets-0.59%
Miscellaneous
EmployeesN/A
Outstanding Shares19,700,000
Market Cap$53.53 million
InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions
What is InfuSystem's stock symbol?
InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."
How will InfuSystem's stock buyback program work?
InfuSystem declared that its Board of Directors has authorized a stock buyback program on Tuesday, March 13th 2018, which authorizes the company to buyback 1,000,000 outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its stock is undervalued.
How were InfuSystem's earnings last quarter?
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings data on Tuesday, August, 14th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $16.42 million for the quarter. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%. View InfuSystem's Earnings History.
When is InfuSystem's next earnings date?
Who are some of InfuSystem's key competitors?
Some companies that are related to InfuSystem include Tristel (TSTL), TSO3 (TOS), Clover (CLV), Bovie Medical (BVX), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX), Relevium Technologies (RLV), Vigil Health Solutions (VGL), Iris BioTechnologies (IRSB), SECTOR 10 (SECI) and Bovie Medical (BVX).
Who are InfuSystem's key executives?
InfuSystem's management team includes the folowing people:
- Mr. Richard A. DiIorio, Pres, CEO & Director (Age 43)
- Ms. Janet Skonieczny, Consultant (Age 58)
- Mr. Christopher S. Downs, Former Exec. VP, Interim CFO & Member of Office of the Pres (Age 39)
- Mr. Gregory Schulte, Exec. VP & CFO (Age 51)
- Mr. Tom Ruiz, Sr. VP of Sales & Marketing
Has InfuSystem been receiving favorable news coverage?
Media headlines about INFU stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. InfuSystem earned a news and rumor sentiment score of 0.18 on Accern's scale. They also gave news coverage about the medical instruments supplier an impact score of 46.57 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for InfuSystem.
Who are InfuSystem's major shareholders?
InfuSystem's stock is owned by a number of of institutional and retail investors. Top institutional investors include Gabelli Funds LLC (1.23%), Renaissance Technologies LLC (1.17%), FineMark National Bank & Trust (1.12%), Dimensional Fund Advisors LP (0.76%) and LSV Asset Management (0.54%). Company insiders that own InfuSystem stock include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, David C Dreyer, Eric K Steen, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Ryan J Morris, Scott Shuda and Terry L Armstrong. View Institutional Ownership Trends for InfuSystem.
Which major investors are selling InfuSystem stock?
Which major investors are buying InfuSystem stock?
INFU stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, FineMark National Bank & Trust and Gabelli Funds LLC. Company insiders that have bought InfuSystem stock in the last two years include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Eric K Steen, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Ryan J Morris, Scott Shuda and Terry L Armstrong. View Insider Buying and Selling for InfuSystem.
How do I buy shares of InfuSystem?
Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InfuSystem's stock price today?
One share of INFU stock can currently be purchased for approximately $3.30.
How big of a company is InfuSystem?
InfuSystem has a market capitalization of $53.53 million.
How can I contact InfuSystem?
InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.
MarketBeat Community Rating for InfuSystem (NYSEAMERICAN INFU)
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe INFU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days.
